Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 3.400
+0.040 (1.19%)
Nov 6, 2026, 5:35 PM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €803.35 million as of November 6, 2026. It is the 10,553rd most valuable company in the world and the 153rd biggest in France. Its market cap has increased by 60.64% in one year.
Market Cap
803.35M
Enterprise Value
776.01M
Revenue
2.46M
Global Rank
Country Rank
#153 France
PE Ratio
n/a
ChartMarket Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 803.35M, an increase of 497.09%. That is a compound annual growth rate of 20.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 803.35M | 6.60% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 6.73B |
| Nanobiotix | 1.37B |
| MedinCell | 1.02B |
| DBV Technologies | 564.00M |
| Genfit | 530.33M |
| Valneva SE | 476.02M |
| Valerio Therapeutics Société anonyme | 234.74M |
| Transgene | 204.86M |